Finally, systemic administration of tCoa-NGR in mice bearing 4T1 murine mammary or PC3 human prostate xenografts resulted in a striking reduction in tumor growth of both sex steroid-driven distinct tumor types. The gene discussed is RTN4R; the disease is neoplasm.